GlassScriptPhysician profile
Kenneth A Konsker
NPI 1154309771
$930.15
in general payments reported to CMS, 2019-2025
15 companies · $399 in 2025
The $399 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $16.36 · 2021: $120 · 2022: $21.39 · 2023: $46.98 · 2024: $176 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $242.54 | 2019-2025 | 3dimensions, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Astellas Pharma US INC | $127.59 | 2025 | Veozah |
| Amag Pharmaceuticals, INC. | $118.57 | 2019 | |
| Medicem INC. | $99.73 | 2021 | |
| Abbvie INC. | $95.25 | 2024-2025 | |
| Radiometer America, INC | $80.58 | 2024 | |
| Organon LLC | $25.78 | 2024 | |
| Lilly USA, LLC | $24.59 | 2025 | Zepbound |
| Optumhealth Care Solutions, LLC | $21.85 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Novo Nordisk INC | $20.55 | 2025 | Wegovy |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Coopersurgical, INC. | $18.68 | 2025 | Onetrac Lx |
| Millicent US INC | $17.41 | 2025 | Intrarosa, Femring |
| Pfizer INC. | $17.03 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Konsker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.